Aug 10, 2026 02:33AM

Aug 10, 2026 02:32AM

Jun 26, 2026 04:02PM

Jun 26, 2026 03:59PM

May 26, 2026 10:46AM

Oct 19, 2025 03:59PM

Jun 27, 2025 07:37PM FDA approves Gamifant® (emapalumab-lzsg) as first-ever treatment for adults and children with Macrophage Activation Syndrome in Still's disease

Nov 7, 2024 06:59AM

Oct 30, 2024 03:24AM

Jul 16, 2024 05:17AM

Jul 2, 2024 02:23AM

Jun 19, 2024 02:17AM

May 24, 2024 03:16PM

Apr 26, 2024 08:02AM Sobi® receives positive CHMP opinion recommending approval of efanesoctocog alfa for once-weekly treatment of haemophilia A

Nov 20, 2023 02:36AM

Jul 18, 2023 04:39AM

Jun 26, 2023 09:45AM

Jun 25, 2023 11:18AM

Jun 24, 2023 06:49AM

May 30, 2023 04:35PM

May 19, 2023 01:58AM EMA validates marketing authorisation application for efanesoctocog alfa for treatment of haemophilia A

May 10, 2023 01:32AM

Apr 4, 2023 07:00AM

Mar 21, 2023 03:51AM

Nov 11, 2022 05:04AM

Nov 10, 2022 07:00AM

Oct 27, 2022 06:59AM

Jul 8, 2022 02:59AM Sobi to license loncastuximab tesirine from ADC Therapeutics

Jul 8, 2022 02:00AM

Mar 9, 2022 01:14AM

Nov 4, 2021 10:45AM

Sep 7, 2021 08:00AM

Jul 7, 2021 02:11AM

Jun 1, 2021 02:39AM

May 25, 2021 07:54AM Positive top-line results from the phase 3 PRINCE study of pegcetacoplan in treatment-naïve patients with PNH

Mar 17, 2021 05:48PM

Mar 12, 2021 03:12AM

Jan 20, 2021 02:58AM

Dec 22, 2020 10:36AM

Dec 11, 2020 07:09AM

Dec 10, 2020 06:18AM

Dec 10, 2020 06:10AM Apellis Pharma (APLS), Sobi Report Positive Top-line Results at 48 Weeks from the Phase 3 PEGASUS Study of Pegcetacoplan in PNH

Dec 10, 2020 06:00AM

Dec 10, 2020 03:54AM

Nov 19, 2020 06:58AM

Nov 19, 2020 06:45AM

Nov 6, 2020 09:17AM

Nov 4, 2020 02:54AM

Oct 9, 2020 07:36AM Sobi announces topline phase 3 data of avatrombopag for the treatment of Chemotherapy-Induced Thrombocytopenia

Sep 30, 2020 05:43PM

328,819 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All